Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The most common adverse events during the lead-in period were nausea, diarrhea, constipation and vomiting, and most events were mild or moderate
It is important to monitor progress with a new treatment or therapy
Patients should be alert for signs of dehydration that could lead to acute kidney injury, especially with severe diarrhea
:format(webp))
Switching from a denied Wegovy to a covered Zepbound (or vice versa) is sometimes the fastest route to therapy
After six cycles, the treatment efficacy was evaluated as Partial Response (PR)
Price: Rs
US$ 24.54
US$ 28.57
US$ 20.15
US$ 22.44
US$ 29.60
US$ 21.27
US$ 29.96
US$ 27.36
